| Name | Title | Contact Details |
|---|
Luminus Devices develops and manufactures products that enable illumination applications around the world. Patented, high performance Luminus LEDs are the brightest and most versatile solid state light sources available today, redefining the solid state lighting landscape by enabling the adoption of LED technology into emerging markets. Luminus technology is used in commercial and industrial lighting fixtures, theatrical lighting, projectors, signs, medical equipment, UV curing… just about anywhere a bright, efficient, reliable, long-life light source is needed.
ArterisIP provides Network-on-Chip interconnect IP to SoC makers so they can reduce cycle time, increase margins, and easily add functionality. Unlike traditional solutions, Arteris’ plug-and-play technology is flexible and efficient, allowing designers to optimize for throughput, power, latency and floorplan. Using ArterisIP solves pain for our customers. Traditional bus and crossbar interconnect approaches create serious problems for architects, digital and physical designers, and integrators: Massive numbers of wires, increased heat and power consumption, failed timing closure, spaghetti-like routing congestion leading to increased die area, and difficulty making changes for derivatives. ArterisIP NoC IP reduces the number of wires down to one half, results in fewer gates, fewer and shorter wires, and a more compact chip floor plan. Having the option to configure each connection’s width, and each transaction’s dynamic priority assures meeting latency and bandwidth requirements. And with the Arteris IP configuration tool suite, design and verification can be done easily, in a matter of days or even hours. Arteris invented NoC technology, offering the first commercial solution in 2006, and is now the choice for many major semiconductor manufacturers including TI, NEC and others. Between tapeouts, production projects and benchmarks, ArterisIP has shipped in over 100 SoCs.
Ann's Hallmark is a Anaheim, CA-based company in the Computers and Electronics sector.
Grandis is a Milpitas, CA-based company in the Computers and Electronics sector.
Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.